In the intricate world of pharmaceutical manufacturing, the quality and availability of key intermediates are paramount. One such vital compound is 2,N-Dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol, identified by its CAS number 100442-33-9. This chemical entity plays a pivotal role as an intermediate, most notably in the synthesis of Lercanidipine, a widely prescribed medication for managing hypertension. Understanding the function and sourcing of this compound is crucial for any organization involved in the pharmaceutical supply chain.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the indispensable nature of 2,N-Dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol in modern drug development. Its molecular structure, C20H27NO, and molecular weight of 297.43 g/mol, are specifically tailored to facilitate complex organic synthesis reactions. The compound's pale yellow liquid appearance is a common characteristic, and its consistent purity is a non-negotiable requirement for pharmaceutical applications. The price of this intermediate can vary based on purity, quantity, and supplier, making strategic sourcing a key consideration for manufacturers seeking to optimize production costs while maintaining high quality.

The journey from raw materials to a finished pharmaceutical product is a complex one, often involving multiple synthetic steps. 2,N-Dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol serves as a critical linker or building block, enabling the formation of the desired Lercanidipine molecule. The efficiency of this synthesis is directly tied to the quality of the intermediate. Manufacturers often look for suppliers who can guarantee batch-to-batch consistency and adherence to stringent quality standards. The ability to purchase this compound in bulk quantities is also a significant factor for large-scale production facilities.

The demand for effective antihypertensive drugs like Lercanidipine remains consistently high, driving the need for a stable and reliable supply of its intermediates. Companies that specialize in fine chemical synthesis and pharmaceutical intermediates, such as NINGBO INNO PHARMCHEM CO.,LTD., are instrumental in meeting this demand. By focusing on the precise chemical synthesis pathways and maintaining rigorous quality control, these suppliers ensure that the intermediates they provide are of the highest caliber, ultimately contributing to the production of safe and effective medicines that benefit global health.